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Neurons residing in the gut-brain axis remain understudied despite their important role
in coordinating metabolic functions. This lack of knowledge is observed, in part, because
labeling gut-brain axis neurons and their connections using conventional neuroanatomical
methods is inherently challenging. This article summarizes genetic approaches that enable
the labeling of distinct populations of gut-brain axis neurons in living laboratory rodents.
In particular, we review the respective strengths and limitations of currently available
genetic and viral approaches that permit the marking of gut-brain axis neurons without
the need for antibodies or conventional neurotropic tracers. Finally, we discuss how these
methodological advances are progressively transforming the study of the healthy and
diseased gut-brain axis in the context of its role in chronic metabolic diseases, including
diabetes and obesity.
Keywords: vagus nerve, mouse models, autonomic nervous system, morphology, obesity
“These nerves [to the bowels] are but small, because the parts serving
for nutrition, needed none but little nerves, for the performance of
the third duty of the nerves, which is in the discerning and knowing
of what is troublesome to them [. . .]. We have this benefit by this
sense, that as soon as anything troubles and vellicates the bowels, we
being admonished thereof may look for help in time”
–Ambroise Paré, circa 1579.
OVERVIEW OF THE ANATOMICAL STUDY OF THE GUT-BRAIN
AXIS
The gut-brain axis comprises a network of autonomic neurons
that connect the central nervous system (CNS)—specifically, the
caudal brainstem and spinal cord—to the esophagus, gastroin-
testinal tract, liver, and pancreas (Loewy and Spyer, 1990; Janig,
1996; Powley, 2000; Gibbins et al., 2003; Furness, 2006). The
axons of these neurons travel through the vagus, splanchnic,
mesenteric and pelvic spinal nerves to innervate the abdominal
Abbreviations: AP, area postrema; BAC, bacterial artificial chromosome; β-gal,
β–galactosidase; CNS, central nervous system; CGRP, calcitonin gene-related
peptide; ChAT, choline acetyltransferase; CMV, cytomegalovirus; Cre, Cre-
recombinase; DBH, dopamine β-hydroxylase; DMV, dorsal motor nucleus of the
vagus; DRG, dorsal root ganglion; eGFP, enhanced GFP; eGFPf, enhanced GFP far-
nesylated; GAD, glutamic acid decarboxylase; GHSR, ghrelin receptor; GFP, green
fluorescent protein; IML, intermediolateral cell column; IRES, internal ribosome
entry site; MC4R, melanocortin-4 receptor; mp, myenteric plexus; NTS, nucleus
of solitary tract; NG, nodose ganglion; PNS, peripheral nervous system; Phox2b,
paired-like homeobox 2b; POMC, proopiomelanocortin; PRS, noradrenergic-
specific Cis element; preSVG, prevertebral sympathetic ganglion; rAAV, recombi-
nant adeno-associated viruses; RSV, rous sarcoma virus; smp, submucosal plexus;
TB, transcription blocker; TH, tyrosine hydroxylase; UTR, untranslated region; X,
vagus nerve.
viscera. Figure 1 provides a simplified overview of the anatomy of
the mammalian gut-brain axis and its major components. While
the general organization of the gut-brain axis appears relatively
simple compared to that of the CNS, the neurochemical, anatom-
ical and functional relationships between different populations
of gut-brain axis neurons can be highly complex (Anlauf et al.,
2003; Travagli et al., 2003; Powley et al., 2005; Lomax et al., 2006;
Bertrand, 2009; Brierley, 2010; Fox, 2013). Notably, the anatom-
ical study of gut-brain axis has a remarkably long history. For
instance, the vagus nerve was already known to Galen (circa A.D.
130–200) (Ackerknecht, 1974). Furthermore, Renaissance physi-
cians were aware of the importance of the nerve supply to the
gut in discerning, as put by Ambroise Paré (Paré, 1968), what
is troublesome to the bowels. However, the detailed anatomy of
the gut-brain axis remained inaccessible to biologists for a long
time because the nerves immediately cease to be distinguishable
as they penetrate into peripheral organs. Thus, it was not until
the late nineteenth century that postganglionic neurons located
in the gastrointestinal wall (also known as enteric neurons) were
discovered by Auerbach andMeissner (Meissner, 1857; Auerbach,
1863). Enteric neurons, along with postganglionic neurons in
the gallbladder and pancreas, are part of the gut-brain axis, as
they receive direct input from, and transmit information to, the
rest of the autonomic nervous system; however, enteric neurons
are also capable of operating independently of the gut-brain axis
(Gershon, 1981; Morris et al., 1985; Mawe et al., 1997; Powley,
2000).
Using Golgi staining (DeFelipe, 2010), histologists in the
beginning of the twentieth century continuously refined our
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FIGURE 1 | Simplified organization of the gut-brain axis. The main
anatomical and functional subdivisions of a mammalian gut-brain axis are
represented with neurons belonging to the enteric and extrinsic autonomic
systems in different colors. Importantly, the enteric nervous system is
entirely contained within the gastrointestinal wall. For purposes of
simplification, all the nerve branches supplying the gut, pancreatic
post-ganglionic neurons and the sacral parasympathetic system are not
depicted in this figure.
understanding of the intricate networks of neurons of the
gut-brain axis. Despite its indubitable value, Golgi staining
remained capricious. As a result, neuroanatomists have developed
more reliable ways of interrogating the organization of the gut-
brain axis in recent decades. First, a large number of anatomical
studies using the injection of retrograde tracers or neurotropic
viruses into visceral tissues have revealed the connections between
autonomic nerves and their gastrointestinal targets (Sharkey
et al., 1984; Sterner et al., 1985; Altschuler et al., 1989; Rinaman
et al., 1999; Rinaman and Schwartz, 2004). Although useful,
these newer approaches did not provide a means of labeling
autonomic peripheral endings. In addition, retrograde tracing
techniques (gut-to-brain) using neurotropic viruses or tracers
to verify connections between autonomic neurons and periph-
eral tissues can potentially produce false-positive results (Fox and
Powley, 1986; Berthoud et al., 2006). Moreover, the interpreta-
tion of data obtained with neurotropic rabies virus (which travels
in a multisynaptic manner) is complicated by the fact that the
vagus nerve innervates sympathetic and pelvic ganglia (Berthoud
and Powley, 1993), which makes it difficult to ascertain the neu-
ral routes taken by these viruses. Alternatively, immunolabeling
can be useful in identifying select neuropeptides, neurotrans-
mitters, enzymes and receptors found in vagal and/or spinal
visceral endings (Furness and Costa, 1980; Green and Dockray,
1987; Patterson et al., 2002; Chiocchetti et al., 2003; Wang and
Neuhuber, 2003; Lindsay et al., 2006; Phillips and Powley, 2007;
Mitsui, 2009; Bellier and Kimura, 2011). Unfortunately, specific
molecular markers that could be used to selectively label different
types of autonomic nerve endings in a systematic manner are
still lacking. In addition, the staining obtained with antibod-
ies might not always be distributed evenly in a neuron, and the
expression levels of many molecular markers can fluctuate due to
experimental conditions. Second, studies employing anterograde
tracer (brain-to-gut) injections have been essential to our current
understanding of the basic morphology and anatomical distribu-
tion of gut-brain axis neurons (Berthoud et al., 1991; Fox et al.,
2000; Wang and Powley, 2000; Walter et al., 2009; Zagorodnyuk
et al., 2010). Needless to say, those previous studies have served as
invaluable references for scientists interested in the gut-brain axis
and have revealed many different types of specialized neuronal
endings with distinct shapes, functions and tissue distributions in
the gut. Details of the variety of receptors found in the gut are
available in several publications (Fox et al., 2000; Berthoud et al.,
2004; Powley et al., 2011). On a more practical level, however,
tracer experiments inherently produce variable results and some
degree of tissue damage at the site of injection. Furthermore,
tracer injections are laborious and are not always compatible with
long-term physiological experiments given the relatively short
life of conventional neural tracers, and, in the case of peripheral
ganglia, tracer injections remain technically challenging.
Due to the aforementioned limitations, there are still gaps in
our knowledge of the impact of various physiological and patho-
physiological conditions on gut innervation. A better understand-
ing of the anatomy and plasticity of the gut-brain axis will help
to advance our understanding of autonomic neural circuits and
numerous chronic diseases that affect the gut-brain axis, includ-
ing but not limited to inflammatory bowel diseases, metabolic
syndrome, visceral pain, and eating disorders (Mayer and Collins,
2002; Powley et al., 2005; Faris et al., 2008; Blackshaw et al., 2010;
Cluny et al., 2012; Larauche et al., 2012; Raybould, 2012). The
primary goal of this article is to review the principles, advantages,
and limitations of various approaches that permit the genetic
labeling of specific populations of neurons within the gut-brain
axis in temporally and spatially controlled manners. We will focus
on components of the vagus and spinal nerves that innervate
the gut; however, the methods described in this article can also
be applied to other components of the peripheral nervous sys-
tem (PNS). Further information on the mapping of peripheral
nociceptive, somatosensory and somatomotor pathways using
reporter mice can be found elsewhere (Tucker et al., 2001; Nguyen
et al., 2002; Basbaum andBraz, 2010; Li et al., 2011;Whitney et al.,
2011). Although this article focuses on the anatomy of the adult
gut-brain axis (rather than its physiology), the usefulness of trans-
genic tools in studying the metabolic functions of the gut-brain
axis will be briefly discussed in the last section.
LABELING GUT-BRAIN AXIS NEURONSWITH TRANSGENIC
TECHNOLOGIES
SURROGATE REPORTERS
Principle, advantages, and limitations
Several mouse models that express fluorescent reporter proteins
in subsets of gut-brain axis neurons have been described in the
literature (Table 1). These mice generally possess a transgene
incorporating the regulatory elements of a gene endogenously
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Table 1 | Non-exhaustive list of the genetic models employed to introduce reporter expression in the rodent gut-brain axis.
Mouse line Construct Reporter(s) Labeled gut-brain Reference(s)
or virus name axis neurons
CONSTITUTIVE EXPRESSION OF REPORTER
CGRPα-GFP Knockin of eGFPf in Calca locus eGFPf CGRPα DRG neurons McCoy et al., 2012
ChATBAC-eGFP BAC with 78 and 36 kb at 5′and 3′ ends of
Chat and eGFP in exon2
eGFP Cholinergic neurons Tallini et al., 2006
ChAT-6417-LacZ LacZ driven by 5′ fragments of the mouse
ChAT gene
β-gal Naciff et al., 1999
ChAT-tauGFP BAC with entire Chat gene and tauGFP in
exon3
tauGFP Grybko et al., 2011
DBH-lacZ LacZ driven by 5′ fragments of the human
DBH gene
β-gal Noradrenergic neurons Mercer et al., 1991
GAD-EGFP eGFP driven by 1.2 kb of regulatory
elements upstream of mouse Gad1
eGFP Gabaergic NTS neurons Oliva et al., 2000; Bailey
et al., 2008; Gao et al.,
2009
GHSR-eGFP BAC containing eGFP driven by GHSR
promoter
eGFP Subgroup of
preganglionic
sympathetic neurons
Furness et al., 2011, 2012
MC4R-GFP BAC containing Tau-sGFP inserted in the
ATG site of Mc4r
tau-sGFP Subgroup of NG, DMV
and DRG neurons
Kishi et al., 2003;
Gautron et al., 2010a,
2012
Peripherin-eGFP BAC with eGFP driven by the entire human
hPRPH-1 gene
eGFP Peripherin-containing
neurons
McLenachan et al., 2008
Phox2b-H2BCFP BAC with Histone2B-fused with cerulean
inserted into the first exon of Phox2b locus
cerulean Autonomic neural
crest-derived cells
Corpening et al., 2008
POMC-EGFP EGFP inserted in exon 2 of murine Pomc
with 13 kb of 5′ and 2 kb of 3′ regulatory
sequences
eGFP NTS POMC neurons Fan et al., 2004;
Appleyard et al., 2005;
Padilla et al., 2012
CRE-DEPENDENT EXPRESSION OF REPORTER
ChAT-IRES-Cre IRES-Cre inserted in ChAT exon 15 GFP, tdTomato Cholinergic neurons Rossi et al., 2011;
Gautron et al., 2013a
ChAT-Cre BAC with Cre inserted into the first exon of
ChAT locus
eGFP Cholinergic neurons Gong et al., 2003
Nav1.8-Cre Cre knocked into Nav1.8 locus β-gal, tdTomato Nav1.8-expressing
afferents
Stirling et al., 2005;
Gautron et al., 2011;
Shields et al., 2012
Nav1.8-Cre (or SNS-Cre) BAC of Nav1.8 locus containing Cre β-gal Agarwal et al., 2004
Phox2bcre BAC containing Cre inserted in Phox2b
exon 2
YFP All autonomic neurons
but sympathetic
preganglionic
D’Autreaux et al., 2011
Phox2b-Cre BAC containing Cre inserted in Phox2b
exon 1
EGFP DMV and NTS Gong et al., 2003
Phox2b-Cre Cre driven by Phox2b with >75 kb at 3′ and
5′ ends
GFP, β-gal,
tdTomato
DMV, NG, subset of
NTS and enteric
neurons
Rossi et al., 2011; Scott
et al., 2011; Gautron
et al., 2013b
POMC-Cre BAC containing Pomc locus with Cre
inserted in exon 2
eGFP,
tdTomato
NTS POMC neurons Balthasar et al., 2004;
Padilla et al., 2012
TH-Cre IRES-Cre knocked in 3′UTR of TH gene YFP, β-gal Catecholaminergic
neurons
Lindeberg et al., 2004;
Obermayr et al., 2013
VIRALLY DELIVERED REPORTER
AAV (serotypes) CMV-driven eGFP eGFP Majority of NG neurons Kollarik et al., 2010
AdRSVlacZ RSV-driven LacZ β-gal Majority of cultured NG
neurons
Meyrelles et al., 1997
AdCMVlacZ CMV-driven LacZ
AdRSVgfp RSV-driven GFP GFP
(Continued)
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Table 1 | Continued
Mouse line Construct Reporter(s) Labeled gut-brain Reference(s)
or virus name axis neurons
PRSx8-AlstR-eGFP-LV eGFP driven by Phox2b-activated promoter eGFP DMV neurons at site of
injection
Mastitskaya et al., 2012
PRSx8-ChIEFtdTomato-AV tdTomato driven by Phox2b-activated
promoter
tdTomato
rAAV8-GFP CMV-driven GFP GFP Subgroup of DRG
neurons innervating the
colon
Storek et al., 2008;
Vulchanova et al., 2010;
Schuster et al., 2013
For abbreviations and references, see the text.
expressed in gut-brain axis neurons and a green fluorescent pro-
tein (GFP) gene or one of its variants. Different approaches for
inserting a transgene into the genome exist, but most of the
mice discussed in this article were generated either using bacterial
artificial chromosome (BAC transgene) or knock-in (inserted in
the endogenous allele) approaches. Both approaches have advan-
tages and issues, which are described in more specialized articles
(Gong et al., 2003; Dhaliwal and Lagace, 2011; Heffner et al.,
2012; Murray et al., 2012). Nonetheless, it is important to remem-
ber that the insertion of a transgene into the genome with the
BAC approach is random. Due to this random insertion, trans-
gene expression does not always perfectly recapitulate that of the
endogenous gene. In contrast, the knock-in approach produces
reporter expression that is under the control of endogenous reg-
ulatory sequences, which results faithful expression patterns. In
all cases, ectopic transgene expression can occur, and the distri-
bution of the reporter must be systematically compared to that of
the endogenous gene of interest.
GFP is a widely used fluorescent reporter that is well-
transported and allows for the labeling of terminal endings in
both the periphery and CNS. In addition, constitutive reporters
closely reflect the endogenous expression of one particular gene
of interest at any given time and can allow for the labeling of
cells that are otherwise difficult to detect using conventional
anatomical methods (Padilla et al., 2012). GFP reporters, how-
ever, are not without caveats. For instance, GFP is not always
bright enough to be observed without immunostaining (Liu et al.,
2003). Fortunately, antisera against GFP that can be used to stain
GFP-containing structures are widely available. The marking of
cells with GFP reporters is not permanent, and, consequently,
these reporters can be useful in studies that aim to examine
dynamically regulated proteins (via the resulting up- or down-
regulation of GFP). However, this feature can also be a drawback
if the primary goal of the study is fate mapping or the permanent
labeling of a group of neurons across physiological circumstances.
Finally, GFP has been reported to be potentially toxic to brain
cells at high expression levels (Howard et al., 2008). Although
it does not have the versatility of fluorescent reporters, another
reporter protein commonly employed in molecular biology is the
β-galactosidase enzyme, which is encoded by the lacZ gene. Cells
expressing lacZ can be labeled in straightforward manner with a
blue dye.
Review of available tools
The choline acetyltransferase (ChAT) gene encodes the enzyme
necessary for the synthesis of acetylcholine, the principal neu-
rotransmitter of preganglionic parasympathetic and sympathetic
neurons and a large proportion of enteric neurons (Arvidsson
et al., 1997). A transgenic mouse with lacZ expression that is
restricted to cholinergic neurons was generated more than a
decade ago (Naciff et al., 1999). This study also established the
regulatory sequence in the ChAT locus that is necessary to drive
specific lacZ expression in cholinergic neurons. Dorsal motor
nucleus of the vagus (DMV) neurons have been stained in this
mouse, but other gut-brain axis neurons have not been examined.
More recently, ChATBAC-eGFP and ChATBAC-tau-GFP animals
were generated using a BAC strategy (Tallini et al., 2006; Grybko
et al., 2011). In both lines, the expression of either enhanced
GFP (eGFP) or tau-GFP is under the control of the ChAT pro-
moter. Tau is a microtubule-binding protein and, consequently,
tau-GFP fusion protein is more effectively transported to termi-
nal processes than GFP alone. As anticipated, the fluorescence
in these two lines has been reported in all cholinergic neurons
including, DMV and enteric neurons. A study by Grybko and
colleagues demonstrated bright native GFP fluorescence that per-
fectly colocalized with ChAT immunoreactivity. Although these
animals have not been characterized in depth (e.g., with ectopic
expression), they appear to be useful for the study of cholinergic
gut-brain axis neurons.
Melanocortin-4 receptor (MC4R) is an important molecular
player in the regulation of feeding, metabolic, and autonomic
functions (Cone, 2005). Not surprisingly, MC4R is expressed
in gut-brain axis neurons including subsets of both motor and
sensory vagal and spinal neurons (Kishi et al., 2003; Gautron
et al., 2010a, 2012). MC4R-GFP mice that express tau-sapphire-
GFP fusion protein under the control of the MC4R regulatory
sequences have been generated (Liu et al., 2003) (Figure 2A).
These mice express GFP in subgroups of nodose ganglion (NG)
and DMV neurons, as well as in preganglionic sympathetic neu-
rons (Liu et al., 2003; Gautron et al., 2010a), and the GFP is
present only in MC4R-expressing neurons. Interestingly, GFP is
transported to the terminal endings of vagal neurons within the
gastrointestinal tract and, hence, reveal the peripheral targets
of MC4R in the hepatic artery, myenteric plexus and intestinal
mucosa (Gautron et al., 2010a).
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FIGURE 2 | Representative examples of transgenic approaches that
enable the marking of restricted gut-brain axis neurons in the mouse.
(A) Vagal sensory neurons in the NG of MC4R-GFP mouse stained with an
anti-GFP antibody and diaminobenzidine. Notably, both the cell bodies and
axons of vagal sensory neurons are clearly labeled. (B,D) Fluorescently
labeled terminal fibers in the dorsovagal-complex and duodenummucosa of
a Nav1.8-Cre-tdTomato mouse. (C) Whole-mount of the ileal myenteric
plexus of a Phox2b-Cre-tdTomatomouse revealing vagal extrinsic
innervation and isolated innervation of enteric neurons. (E) Whole-mount of
the gastric myenteric plexus of a ChAT-Cre-tdTomato mouse containing
fluorescent preganglionic fibers intermingled with cholinergic enteric
neurons that reveals the myenteric plexus. The above images are all
unpublished and were generated in our laboratory using mouse lines
described in the article.
A mouse that expresses eGFP under the ghrelin receptor
(GHSR) promoter was recently characterized (Furness et al.,
2011). Simply expressed, ghrelin is a hormone secreted by the
stomach epithelium that promotes hunger and modulates auto-
nomic functions (Nogueiras et al., 2008). Using double-labeling
and retrograde tracer experiments, a subgroup of preganglionic
sympathetic neurons, including neurons connected to the gut
(as evidenced by retrograde tracing experiments), has been
identified to contain eGFP (Furness et al., 2012). The projec-
tions of these neurons terminating in sympathetic ganglia are
nicely labeled by eGFP immunohistochemistry. These data sug-
gest that GHSR-eGFP mice are a valid model for identifying
GHSR-expressing gut-brain axis neurons. As GHSR mRNA has
been reported to be present in NG and DMV neurons (Date
et al., 2002; Zigman et al., 2006), further work to determine
whether vagal neurons are labeled in this reporter model is
warranted.
GABAergic interneurons located in the nucleus of solitary tract
(NTS) play a critical role in vago-vagal reflexes (Bailey et al.,
2008). GAD-EGFP mice express eGFP under the control of the
glutamic acid decarboxylase-67 gene (aka Gad1) (Oliva et al.,
2000). The vast majority of GFP-positive cells are immunoreac-
tive for GABAergic markers. Many brain sites known to contain
GABAergic neurons do not display GFP fluorescence, which sug-
gests GFP underexpression. Brainstem slices from the GAD-EGFP
mouse have been employed to facilitate the patch-clamping of
interneurons in the dorsovagal complex to conduct detailed mea-
surements of their electrophysiological properties in response to
vagal afferent stimulation (Bailey et al., 2008; Gao et al., 2009).
Paired-like homeobox 2b (Phox2b) is a transcription factor
that is critically involved in the early differentiation of auto-
nomic and viscerosensory pathways (Brunet and Pattyn, 2002).
The neural precursors of many gut-brain axis neurons express
Phox2b during development including virtually all parasympa-
thetic, enteric and sympathetic ganglia neurons (Tiveron et al.,
1996). One mouse line expressing a fused Histone2B-cerulean
protein under the control of Phox2b was generated using a BAC
strategy to mark enteric progenitors (Corpening et al., 2008). The
reporter strictly localizes to the nucleus, rendering the identifi-
cation of adjacent neurons straightforward. Expression of this
transgene has been demonstrated in Phox2b cells in the CNS,
sympathetic chain and enteric system, which agrees with the
known distribution of Phox2b. However, it is not clear whether
vagal neurons express the transgene. Double-labeling with an
antibody against Phox2b further validated the genuine distribu-
tion of the transgene in Phox2b cells in the developing and adult
gut. Thus, far, this model has primarily been used to monitor the
migration of enteric progenitors in the developing murine gut
and to identify adult neural crest derived cells (Corpening et al.,
2008).
Proopiomelanocortin (POMC) is a precursor of several pitu-
itary and hypothalamic peptides that is important in neuroen-
docrine and metabolic functions (Liu et al., 1992; Cowley et al.,
2001). TheNTS contains a small population of POMC-expressing
neurons (Padilla et al., 2012). Unlike other POMC cells, NTS
POMC neurons produce little POMC transcript, rendering their
detection challenging with conventional neuroanatomical tools.
Fortunately, a mouse expressing eGFP under the control of the
regulatory sequence of the murine Pomc gene has been generated
and widely used to visualize NTS POMC neurons (Cowley et al.,
2001; Fan et al., 2004; Appleyard et al., 2005; Padilla et al., 2012).
Specifically, electrophysiological studies using POMC-EGFP ani-
mals have identified NTS POMC neurons as part of a vagovagal
circuit that is implicated in satiation (Appleyard et al., 2005).
Other GFP reporter lines that are potentially interesting for
the study of gut-brain axis neurons include the peripherin-eGFP
(McLenachan et al., 2008) and αCGRP-farnesylated-GFP mice
(McCoy et al., 2012). Peripherin is an intermediate filament that
is not unique to the gut-brain axis but is widely distributed in
the PNS (Troy et al., 1990). The peripherin-eGFP mouse shows
fluorescence in many peripheral sensory neurons and enteric
neurons and their peripheral projections (McLenachan et al.,
2008). It remains unclear whether GFP expression recapitulates
endogenous peripherin gene expression. Calcitonin gene-related
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peptide (CGRP)-α and -β are neuropeptides produced in enteric,
nociceptive and viscerosensory neurons (Mulderry et al., 1988).
The CGRPα-GFP mouse shows GFP immunoreactivity in many
dorsal root ganglion (DRG) neurons and nerve bundles in the
intestines but not in enteric neurons (McCoy et al., 2012). While
all CGRP-immunoreactive DRG neurons display GFP, approx-
imately 30% of GFP neurons are not CGRP immunoreactive,
which raises the question of transgene ectopic expression and/or
subthreshold expression of CGRP.
The dopamine β-hydroxylase (DBH) gene is responsible for
the synthesis of noradrenaline in the autonomic nervous system
(Elfvin et al., 1993). The human β-hydroxylase gene has previ-
ously been employed to drive LacZ expression in the mouse to
identify noradrenergic neurons (Mercer et al., 1991). Several lines
have been produced, including one that expresses β-gal fused with
a nuclear translocation signal. As anticipated, transgene expres-
sion has been reported in sympathetic ganglia, cranial parasym-
pathetic ganglia, the enteric nervous system, and in a small
portion of neurons in the peripheral sensory ganglia (Mercer
et al., 1991). However, the presence of transgene expression in
cholinergic ganglia may be due to ectopic expression.
Finally, while the development of the enteric nervous system
is a field of study that is too vast to be reviewed in the current
article, it is noteworthy that a number of transgenic reporters
have been created to study the fate mapping and differentiation
of enteric neurons during early development (Hanna et al., 2002;
Young et al., 2004; Deal et al., 2006; Corpening et al., 2008, 2011;
Mundell et al., 2012). To avoid oversimplifying this complex area
of research, we deliberately avoid reviewing these models.
Cre/LoxP TECHNOLOGY
Principle, advantages, and limitations
Cre/LoxP technology deserves specific attention, as this approach
profoundly changed how neuroanatomy is conceived and per-
formed (Dymecki andKim, 2007; Livet et al., 2007; Madisen et al.,
2010; Weissman et al., 2011). Figure 3 describes the principles
of the Cre/LoxP technology applied to the labeling of gut-brain
axis neurons. Briefly, by transgenically directing the expression
of Cre-recombinase (Cre) to discrete populations of neurons,
including gut-brain axis neurons (using BAC or gene targeting),
it is possible to induce and modulate the expression of a target
fluorescent reporter in a Cre-responsive manner. Recently, differ-
ent laboratories have taken advantage of availablemouse Cre lines
to specifically manipulate gene expression in autonomic neurons.
To label neurons, select Cre mice can be systematically crossed
with reporter mice that possess a loxP-flanked stop cassette that
prevents the expression of LacZ or a fluorescent reporter protein.
In Cre-expressing neurons, however, the transcriptional termina-
tion sequence is excised allowing reporter production (Madisen
et al., 2010). As an example, mice that express tdTomato in a
Cre-dependent manner are often utilized because tdTomato is
one of the brightest red fluorescent proteins available (Shaner
et al., 2004). Thus, native fluorescence can be observed not only
in the cell bodies but also the central relays and peripheral
endings, which reveals the full extent of Cre-expressing neuron
connectivity. One major advantage of this approach is that it
allows for the permanent labeling of non-replicating cells with a
FIGURE 3 | Principle of an experiment using the Cre-LoxP system to
label specific gut-brain axis neurons in the mouse.
reporter protein. A few examples the utilization of the aforemen-
tioned strategy of labeling gut-brain axis neurons are described
below (see also Table 1). Nonetheless, caution must be taken
when interpreting the distribution of any given Cre-expressing
cell population. Indeed, Cre expression can occur transiently in
developing neurons that do not express the transgene of inter-
est in adulthood, which results in the labeling of cells other
than the intended target neurons (Heffner et al., 2012; Padilla
et al., 2012). Thus, off-target and inconsistent Cre activity must
be considered as potential drawbacks when using the Cre-LoxP
approach.
Review of available tools
Nav1.8 is a tetrodotoxin-resistant sodium voltage-gated chan-
nel that is enriched in C-fiber peripheral afferents, including
a significant proportion of spinal nociceptors, and subsets of
low-threshold mechanoreceptors (Djouhri et al., 2003; Fukuoka
et al., 2008; Shields et al., 2012). It has been clearly estab-
lished that Nav1.8 is essential to the electrogenesis of noci-
ceptors and, as a corollary, certain pain phenotypes including
visceral pain (Laird et al., 2002; Zimmermann et al., 2007).
More surprisingly, expression of Nav1.8 has been demonstrated
in a majority of vagal sensory neurons (Stirling et al., 2005;
Gautron et al., 2012). Transgenic mice expressing Cre under the
control of the Nav1.8 promoter have been generated and char-
acterized (Stirling et al., 2005). In these mice, the translational
start-site of Nav1.8 was substituted with that of Cre recom-
binase. Mice carrying one Nav1.8-cre allele show normal pain
behavior, and their DRG neurons exhibit normal electrophys-
iological properties (Stirling et al., 2005). However, mice with
two Cre alleles are equivalent to Nav1.8 knock-out mice and,
thus, tetrodotoxin-sensitive currents are absent in these mice.
Embryonic and adult Cre recombinase expression reported by
β-galactosidase activity is specific to small diameter neurons in
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the DRG and trigeminal ganglion and many neurons in the
NG. Other than a few neurons in the superior cervical ganglion,
no Cre activity has been observed in peripheral tissues or the
CNS. We, and others, crossed Nav1.8-Cre mice with tdTomato
reporter animals (Gautron et al., 2011; Shields et al., 2012).
In the offspring, all Nav1.8-expressing neurons, including many
vagal and spinal afferents and their connections within the gut
and CNS, are fluorescently marked (Gautron et al., 2011). As
with other examples, we were able to visualize vagal tension
and mucosal endings in the myenteric plexuses of Nav1.8-Cre-
tdTomato mice (Figures 2B,D). Importantly, the numbers and
distribution patterns of tdTomato-positive cells in the DRG and
NG are directly comparable to those of Nav1.8 mRNA, suggest-
ing that Cre activity occurs only in Nav1.8-expressing neurons.
Another mouse expressing Cre under the Nav1.8 promoter also
exists (Agarwal et al., 2004). Because this model was generated
with a BAC, it has the advantage of not disrupting the endoge-
nous Nav1.8 gene in contrast to the knock-in approach described
previously.
ChAT-Cre mice have recently been generated by targeting the
ChAT gene with IRES-Cre (Rossi et al., 2011). Double-labeling
experiments have shown that these mice faithfully express Cre
in cholinergic neurons both in the CNS and PNS. When crossed
with a tdTomato reporter line, the offspring produce tdTomato
in all cholinergic neurons, which allows for distinct labeling of
the cell bodies and projections of all preganglionic sympathetic
and parasympathetic neurons and cholinergic enteric neurons
(Gautron et al., 2013a) (Figure 2C). Importantly, Cre activity
appears to be limited to ChAT-immunoreactive cells. Compared
to the ChAT-GFP lines described previously, ChAT-Cre mice
offer the advantage of allowing the reporter to be invariably
expressed in ChAT cells regardless of ChAT expression levels. This
is important because neuronal ChAT mRNA levels may be dif-
ferentially regulated under different physiological circumstances
(Gibbs, 1996; Castell et al., 2002). Several mouse lines express-
ing Cre under the control of ChAT have also been created in the
context of the Gensat project (Gong et al., 2003). These mice
appear to show restricted Cre activity in cholinergic neurons
including DMV neurons. Little information is available about the
distribution of Cre in other gut-brain axis neurons.
A mouse expressing Cre under the control of Pomc regulatory
elements has been generated with a BAC (Balthasar et al., 2004).
POMC-Cre mice crossed with different inducible reporters have
been used in several laboratories to identify POMC hypothala-
mic and/or NTS neurons (Balthasar et al., 2004; Huo et al., 2006;
Zheng et al., 2010). A recent study revealed significant discrep-
ancies between cells with POMC-Cre activity and POMC-EGFP
transgene expression (Padilla et al., 2012). Specifically, the pop-
ulations of NTS cells labeled by the coexpression of both the
POMC-EGFP and POMC-Cre overlap minimally, which raises
again the issue of possible ectopic and off-target expression.
Several Phox2b-Cre mice have recently been generated by dif-
ferent laboratories (D’Autreaux et al., 2011; Rossi et al., 2011).
Phox2b-Cre mice from the group of Dr. Brunet were crossed
with a YFP reporter mouse to label Phox2b-Cre-expressing neu-
rons (D’Autreaux et al., 2011). As a result, Phox2bCreYFP embryos
show YFP staining in the progenitors of many neurons of the
AP, NTS, DMV, NG, and the enteric nervous system. Phox2b-
Cre mice created by the Gensat project display Cre activity in
the NTS and DMV (Gong et al., 2003). The extent to which
this mouse exhibits Cre in peripheral ganglia is unknown. The
Phox2b-Cre line generated by the Elmquist group was crossed
with a GFP or lacZ reporter mouse and proven to express Cre
in all NG, DMV, and a subgroup of NTS neurons (Rossi et al.,
2011; Scott et al., 2011). The latter mouse did not display Cre
activity in sympathetic neurons and displayed Cre activity in only
a small subset of enteric neurons, suggesting that, presumably
due to positional effects, the expression of Cre underestimates
that of the endogenous Phox2b gene. Nonetheless, this mouse
has proven useful for selectively tagging the vagus nerve. In
Phox2b-Cre-tdTomato mice, distinguishing vagal motor vs. sen-
sory endings remains difficult in locations in which they are
intermingled (i.e., the myenteric plexus); however, the anatomical
integrity of the entire vagus nerve can easily be gauged (Gautron
et al., 2013b) (Figure 2E). In the latter study, we also showed
that Roux-en-Y gastric bypass surgery results in significant vagal
denervation of the stomachs of Phox2b-Cre-tdTomato mice. This
finding is in agreement with observations that suggest signif-
icant morphological and electrophysiological changes in vagal
neurons following gastrointestinal surgical intervention in the rat
(Phillips and Powley, 2005; Guijarro et al., 2007; Browning et al.,
2013b).
Postganglionic sympathetic neurons express tyrosine hydrox-
ylase (TH), the rate-limiting enzyme in catecholamine biosyn-
thesis (Elfvin et al., 1993). Several mice expressing Cre under
the control of the TH promoter have been generated in the past
(Gelman et al., 2003; Lindeberg et al., 2004; Savitt et al., 2005).
Using a TH-Cre knock-in, catecholaminergic gut-brain axis neu-
rons, including sympathetic postganglionic neurons and a small
population of enteric neurons transiently expressing TH during
development, can be marked (Lindeberg et al., 2004; Obermayr
et al., 2013). The patterns of Cre activity have been validated
using TH staining, Cre mRNA in situ hybridization and reporter
distributions (β-gal and YFP).
Remarkably, numerous reagents expressing Cre under the con-
trol of transcription factors implicated in the development of
neural–crest derived tissues (other than Phox2b) are available
(Druckenbrod and Epstein, 2005; Stine et al., 2009; Mundell et al.,
2012). While these models are indispensable for tracking enteric
progenitors migrating in the developing gut, as mentioned before,
it is beyond the scope of this article to review the transgenic tools
used in developmental biology. Lastly, new Cre lines are continu-
ously being generated and are readily available to investigators. A
few examples include neuropeptide Y-, Transient receptor poten-
tial vanilloid receptor 1-, TH-, advilin- and peripherin-Cre mice,
which have all been demonstrated to induce Cre expression in
populations of peripheral afferents and/or brain neurons (Zhou
et al., 2002; Gelman et al., 2003; Braz and Basbaum, 2009; Mishra
et al., 2011; Zurborg et al., 2011). While the genes employed
to drive Cre expression in the latter transgenics are known to
be transcriptionally active in gut-brain axis neurons, insufficient
information is available to assess their usefulness in targeting the
gut-brain axis. Therefore, we will not include these animals in our
review.
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VIRALLY MEDIATED GENE DELIVERY
Principles, advantages, and limitations
Stereotaxic injections of viral vectors of varying packaging capac-
ity, capsid serotype, and cellular tropism are commonly used to
deliver transgenes that encode fluorescent proteins into the CNS
(Klein et al., 2002; Tenenbaum et al., 2004; Luo et al., 2008;
Betley and Sternson, 2011). As illustrated by the examples below,
viral vectors appear adequate to transfer GFP expression in gut-
brain axis neurons; however, few studies have attempted to do
this (Table 1). Generally speaking, viral vectors confer long-term
gene expression and are deliverable to laboratory rodents, non-
human primates and to humans for therapeutic purposes (Kay
et al., 2000; Christine et al., 2009; Bu et al., 2012). While immune
responses to viral particles and toxicity are a concern with certain
viral vectors (Sawada et al., 2010), recombinant adeno-associated
viruses (rAAV) produce little (if any) inflammation (Chamberlin
and Saper, 1998; Lowenstein and Castro, 2002), and virally deliv-
ered transgenes do not integrate into the host genome (Schnepp
et al., 2003). To further minimize neuronal injury, using a glass
micropipette coupled to an iontophoretic or air-pressure set-up
for injection is preferable (Chamberlin et al., 1998; Krenzer et al.,
2011). Interestingly, transgenes transferred by viral vectors can
be Cre-dependent, which allows specific gene expression that is
limited to molecularly defined neurons at the site of injection
(Lazarus et al., 2007; Gautron et al., 2010b; Harris et al., 2012).
However, this strategy is inherently limited by the fact that inject-
ing the NG, DRG, or enteric system is technically challenging.
Finally, the number of transfected neurons at the site of injec-
tion is always inherently variable, and it is not completely clear
whether all gut-brain axis neurons are equally sensitive to viral
transfection.
Review of available tools
Mastitskaya and colleagues recently demonstrated the feasibil-
ity of delivering a few different transgenes encoding engineered
receptors (i.e., allatostatin and channel rhodopsin receptors) into
the rat DMV using a lentivirus and an adenovirus (Mastitskaya
et al., 2012). Of note, both vectors incorporated an artificial
Phox2 promoter to ensure the preferential expression of the
transgenes in the DMV. Each transgene was also coupled with
the expression of a specific fluorescent reporter, either eGFP or
tdTomato. As a result, DMV neurons in brainstem slices could
be visualized by their respective eGFP and tdTomato fluores-
cence and then patched for electrophysiological recordings. This
study is a good illustration of the usefulness of viral vectors in
manipulating gene expression in DMV neurons. There are few
studies that have attempted virally mediated gene delivery in
neurons residing in the peripheral ganglia. Intrathecal delivery
of rAAVs carrying a GFP transgene has been performed in rats
and mice and resulted in the labeling of DRG neurons (Storek
et al., 2008; Vulchanova et al., 2010). Despite the variable transfec-
tion efficiency of this approach, it was recently reported that this
approach can be used to label subsets of DRG neurons that supply
the mouse colon (Schuster et al., 2013). Specifically, GFP-positive
spinal sensory terminals have been observed in the colonic myen-
teric plexus and mucosa of injected mice. Thus, far, only one
study has directly administered AAVs of different serotypes into
the guinea pig NG (Kollarik et al., 2010). Stable expression of
eGFP was successfully obtained in 50–80% of vagal sensory neu-
rons depending on the serotype. The same study indicated that
the injection of an AAV into vagally innervated tissue is suffi-
cient to transfect vagal neurons innervating that tissue (i.e., the
esophagus) and that the eGFP-filled terminal endings of trans-
fected vagal sensory neurons can be observed in the periphery
including the trachea and esophagus. In the case of vagal sensory
neurons, it is also known that a vast majority of primary-cultured
dissociated NG neurons can be successfully transfected with ade-
noviruses driving either LacZ or GFP expression (Meyrelles et al.,
1997).
AREAS OF IMPROVEMENT
Although the rapidly evolving transgenic technologies described
in this article are not meant to replace more conventional
approaches, they offer numerous advantages over classical tracing
and immunohistochemical techniques. In the future, we foresee
that the approaches described in this article will change many
areas of research that require the visualization of visceral affer-
ents, vagal and enteric neurons, especially for scientists who are
not familiar with neuroanatomical techniques. However, trans-
genic technologies have numerous caveats. First, the paucity of
well-characterized mouse lines that permit targeting gut-brain
neurons greatly limits our ability to manipulate the full range of
the different types of gut-brain axis neurons described in the liter-
ature. For example, the development of Cre lines that are adequate
to differentiate vagal stretch (intramuscular arrays) vs. tension
receptors (intraganglionic laminar endings) from mucosal end-
ings would be useful in clarifying the physiological role of each
of the aforementioned vagal endings. It is particularly important
considering that subpopulations of vagal afferents may have com-
pletely different roles in appetite regulation. Moreover, the ability
to differentiate the non-neuronal cells implicated in the normal
functioning of the gut-brain axis, such as glial cells and intersti-
tial cells of Cajal, would be useful (McDougal et al., 2011; Powley
and Phillips, 2011; Gulbransen and Sharkey, 2012). We expect
that this problemwill become smaller in the future as the number
of strains generated by large-scale Cre-driver projects continues
to grow and become available in public repositories (Gong et al.,
2003; Murray et al., 2012). The lack of temporal specificity of the
models described in this article is another problem. For exam-
ple, it would be useful to have the ability to restrict Cre to a
desired life stage. Among other strategies, this could be achieved
using mice that express a Cre-estrogen receptor-fused protein. In
these animals, Cre-induced recombination occurs only following
the exogenous administration of tamoxifen (Badea et al., 2003),
which restricts Cre activity to a desired temporal stage and facil-
itates cell lineage studies. Likewise, the tetracycline system is a
popular technique that is employed to control gene transcription
in a reversible and temporally restricted manner (Schonig et al.,
2013). More inducible Cre drivers relevant to the gut-brain axis
will become available in the future. As mentioned before, ectopic
and/or inconsistent transgene expressions are issues that need to
be addressed when working with transgenic technologies. Lastly,
it must be noted that the physiology of the gut-brain axis has been
extensively studied in guinea pigs and rats instead of mice, and
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these species have not been traditionally targeted for transgenics.
However, transgenic rats, including rat Cre-lines, are becoming
more widely available (Witten et al., 2011; Schonig et al., 2012).
PERSPECTIVES IN METABOLIC RESEARCH
Many investigators acknowledge that identifying the mechanisms
and pathways underlying the central integration of visceral infor-
mation is a true challenge that could provide a better understand-
ing of diseases including obesity (Powley et al., 2005; Berthoud,
2008; Yi and Tschop, 2012). The lack of adequate methods to
interrogate neural pathways linking the gut and the brain has
largely contributed to the slow progress in this area—especially
compared to other areas of sensory biology and somatomotor sys-
tems. To aid the investigation of these pathways, we and others
have begun using and developing new transgenic tools to manip-
ulate gene expression in the gut-brain axis. In the last section,
we will briefly review what is known about the implications of
gut-brain axis neurons in diabetes and obesity and will make
the case that transgenic models can be instrumental in decipher-
ing the role played by the gut-brain axis in chronic metabolic
diseases.
Although hepatic glucose flux is primarily under the direct
control of insulin (Cardin et al., 2002), numerous studies have
found that stimulating vagal efferents alters peripheral glu-
cose flux and insulin secretion (Shimazu and Fujimoto, 1971;
Shimazu, 1971; Rohner-Jeanrenaud et al., 1983; Berthoud et al.,
1990; Rozman and Bunc, 2004; Peitl et al., 2005). Moreover, intact
vagal fibers and capsaicin-sensitive afferents are required for the
normal regulation of hepatic and pancreatic functions (Obici
et al., 2001; Pocai et al., 2005; Razavi et al., 2006; Uno et al., 2006;
Gram et al., 2007) and the anti-diabetic effects of gastric bypass
(Troy et al., 2008). Together, these observations strongly support
the idea that gut-brain axis neurons significantly contribute to
regulating glucose homeostasis. Furthermore, diabetes is a lead-
ing cause of injury to the PNS (Westerman et al., 1989; Drel
et al., 2006), and these injuries may profoundly alter the func-
tioning of gut-brain axis as suggested by the many gastrointestinal
and autonomic symptoms encountered by people with diabetes.
Manipulating the neurons that supply the viscera has also been
proposed as a potentially relevant weight-loss strategy on the
basis of the known regulatory effect of vagal afferents on satia-
tion (Powley et al., 2005). Subdiaphragmatic vagotomy disrupts
food consumption in rodents (Phillips and Powley, 1998; Powley
et al., 2005) and induces weight-loss in humans (Kral, 1978),
but the results of this procedure are difficult to interpret because
vagotomy also impairs gastrointestinal motility. In lean animals,
most studies agree that the selective surgical, genetic, or capsaicin-
induced deafferentation of the vagus nerve results in altered meal
patterns (Chavez et al., 1997; Schwartz et al., 1999; Fox et al.,
2001; Chi et al., 2004) without causing frank obesity or long-term
hyperphagia due to compensatory changes in feeding behavior.
In obese animals, however, capsaicin-induced deafferentation of
the truncal vagus nerve partially prevents diet-induced obesity
(Stearns et al., 2012). Lastly, device–assisted stimulations of the
vagus nerve and stomach wall have entered preclinical trials for
the treatment of obesity (Aronne and Waitman, 2004; Bodenlos
et al., 2007; Camilleri et al., 2008; Val-Laillet et al., 2010), and
several laboratories are currently examining the contributions of
the different branches of the vagus nerve to the beneficial effects
of bariatric surgeries (Bueter et al., 2010; Breen et al., 2012; Shin
et al., 2012).
While the above observations taken together link the gut-brain
axis to diabetes and obesity, we do not yet possess a clear picture
of the contributions of the visceral nerves to the pathophysiolo-
gies of chronic metabolic diseases because vagotomy studies have
generated confounding results and remain inherently limited in
terms of manipulating specific population of vagal afferents. As
the vagus nerve is a mixed nerve, surgical techniques, in addition
to being technically challenging, also result in full or partial loss of
efferent (motor) function. Pharmacological techniques, including
the administration of capsaicin to destroy small-diameter sen-
sory neurons, have been used. However, this method also kills
some neurons in the CNS without killing all vagal sensory neu-
rons (Ritter and Dinh, 1992; Czaja et al., 2008; Browning et al.,
2013a). Additionally, by 60-days post-capsaicin treatment, neu-
ronal nuclei in the NG of rats are not different from controls
(Czaja et al., 2008), which limits the applicability of this approach
for studying long-term regulation by the sensory vagus nerve.
Furthermore, regeneration/plasticity of some sensory terminals
after vagotomy has been reported (Phillips et al., 2000). Newly
developed genetic tools have emerged to circumvent many of the
aforementioned problems. First, transgenic reagents can be par-
ticularly useful in studies seeking to knock-out or “reactivate”
genes in autonomic pathways relevant to the regulation of periph-
eral glucose flux and insulin secretion. For example, a few recent
studies have employed Cre-LoxP technology to selectively reac-
tivate MC4R expression in preganglionic vagal and sympathetic
neurons and demonstrated the key role of this receptor in ame-
liorating diabetes in MC4R null mice (Rossi et al., 2011; Zechner
et al., 2012). Other studies have focused on examining deficits
in neurotrophic factor innervation of the gastrointestinal tracts
of knockout mice and the physiological consequences of these
deficits on feeding (Rossi et al., 2003; Fox, 2013). Second, new
neuromodulation techniques have recently been developed that
allow the genetic targeting of specific neurons with engineered
transmembrane proteins that can exert varied effects on neuronal
activity (Aponte et al., 2011; Krashes et al., 2011). Specifically,
optogenetic techniques involve light-sensitive proteins known as
opsins that alter neuronal activity in response to a blue light.
Pharmacogenetic techniques involve G-coupled proteins recep-
tors that only respond to ligands with no other biological activity.
While these approaches vary in their kinetics and invasiveness,
they both allow the reversible and “remote” control of depolar-
ization or hyperpolarization of targeted neurons within intact
neural circuits. To the best of our knowledge, only one study has
employed these new strategies to modulate the activity of DMV
neurons (Mastitskaya et al., 2012). While this study aimed to
interrogate the cardiovascular functions of DMV neurons rather
than gut-related functions, it did provide a proof-of-concept
experiment demonstrating that opto- and pharmacogenetics have
the potential to deeply transform the study of the gut-brain axis.
Finally, Cre-LoxP can be used to ablate selective neurons in the
CNS or PNS using an inducible diphtheria toxin system (Luquet
et al., 2005; Abrahamsen et al., 2008). In the future, these methods
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could be applied to the gut-brain axis to perform “molecular
vagotomies” of specific population of vagal neurons.
The above considerations are meant only to illustrate how
transgenic tools can be useful to further our understanding and to
predict the beneficial and deleterious consequences of gut-brain
axis activity modulation by surgical, pharmacological, or device-
assisted means. As the number of transgenic reagents available
to gut-brain axis scientists continues to grow and become more
sophisticated, we predictable that these new tools will play a
critical role in the advancement of our knowledge of the devel-
opment, morphological plasticity, molecular phenotyping, and
connectivity of the healthy and diseased gut-brain axis. In addi-
tion to performing neuroanatomy, one can easily imagine many
applications for these transgenic tools, including, but not limited
to, patch clamp (Bailey et al., 2008; Gao et al., 2009) and flow
cytometry sorting (Buehler et al., 2012) of fluorescently tagged
neurons. Obviously, research on gut-brain axis neurons is not
limited to metabolic diseases but is pertinent to numerous ques-
tions relevant to visceral pain, gut flora homeostasis, whole-body
inflammation and eating disorders, among other examples (Faris
et al., 2008; Andersson and Tracey, 2011; Sharkey and Mawe,
2012). In summary, the rapidly evolving techniques described
in this article have become indispensable and empowered both
anatomists and physiologists with unique tools to understand
better the gut-brain axis in the context of intact animals.
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